CLSD: Clearside Biomedical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 94.15
Enterprise Value ($M) 107.22
Book Value ($M) -15.91
Book Value / Share -0.21
Price / Book -5.92
NCAV ($M) -21.01
NCAV / Share -0.28
Price / NCAV -4.48

Profitability (mra)
Return on Invested Capital (ROIC) -1.20
Return on Assets (ROA) -0.73
Return on Equity (ROE) -3.06

Liquidity (mrq)
Quick Ratio 4.24
Current Ratio 4.24

Balance Sheet (mrq) ($M)
Current Assets 28.92
Assets 34.02
Liabilities 49.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 8.23
Operating Income -24.84
Net Income -32.48
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.14
Cash from Investing -1.78
Cash from Financing 0.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-01 13G/A Whitmore Bradford T 10.10 4.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 62,988 28,502 221.00
2024-04-25 18,961 23,724 79.92
2024-04-24 39,449 49,490 79.71
2024-04-23 114,517 32,954 347.51
2024-04-22 70,308 64,533 108.95

(click for more detail)

Similar Companies
CARM – Carisma Therapeutics, Inc. CGTX – Cognition Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc. CMRX – Chimerix, Inc.
CRMD – CorMedix Inc.


Financial data and stock pages provided by
Fintel.io